null Technology Platforms - Supported by RI


Containment Level 3 (CL3) Platform

A state-of-the-art, multi-pod facility for studies of tuberculosis, influenza and human immunodeficiency virus (HIV).

Fiona McIntosh
Glen Block-E / CTB: ES2.6001
514-934-1934 ext. 44619

Drug Discovery Platform

Structure-based drug design, synthesis and analytical support to discover promising new therapeutics.

Sanjoy Kumar Das
Glen Block-E / CTB: E01.3625.1
514-934-1934 ext. 76350

Histopathology Platform

Accelerating disease research via specimen processing to visualize biological structures and molecules within tissues.

Fazila Chouiali
Glen Block-E / CTB: E01.3082
514-934-1934 ext. 76312

Immunophenotyping Platform

Creating new research opportunities through advances in cell sorting and analytical flow cytometry.

Marie-Hélène Lacombe
Glen Block-E / CTB: E01.5029
514-934-1934 ext. 76352

Molecular Imaging Platform

High-resolution and super-resolution microscopy to drive advances in biomedical research.

Min Fu
Glen Block-E / CTB: E01.5100
514-934-1934 ext. 76401

Proteomics Platform

Advanced instrumentation and streamlined bioinformatics to identify and quantify proteins, and to detect biomolecular changes in health and disease.

Lorne Taylor
Glen Block-E / CTB: E01.5054
514-934-1934 ext. 76402

Small Animal Imaging Labs (SAIL) Platform

A comprehensive technology suite for non-invasive imaging of animal models to create holistic pictures of diseases.

Mathieu Simard
Glen Block-E / CTB: ES2.1602
514-934-1934 ext. 76266